From: Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
 |  | number (%) (n = 88) |
---|---|---|
Age | range: 24-74 | Â |
 | mean: 52 |  |
Smoking | smokers | 25 (28) |
 | non-smokers | 63 (72) |
Tumour grade | 1 | 2 (2) |
 | 2 | 37 (42) |
 | 3 | 49 (56) |
Tumour size | <2cm | 42 (48) |
 | 2 - 5cm | 33 (37) |
 | > = 5cm | 13 (15) |
Surgery | breast conservation | 53 (60) |
 | mastectomy | 34 (39) |
 | no surgery | 1 (1) |
ER/PR status | positive | 57 (65) |
 | negative | 31 (35) |
Her2 status | positive | 16 (18) |
 | negative | 72 (82) |
Nodal status | negative | 38 (43) |
 | positive | 50 (57) |
Chemotherapy | EC/FEC | 39 (44) |
EC + TAX (+G-CSF) | 44 (50) | |
others | 6 (7) | |
neoadjuvant | 18 (20) | |
adjuvant | 70 (80) | |
Endocrine | none | 31 (35) |
 | tamoxifen | 37 (42) |
 | aromatase inhibitors | 20 (23) |
Radiotherapy | yes | 73 (83) |
 | no | 15 (17) |